ChiCTR1900021077 版本V1.0 版本创建时间2019/04/13 09:15:45 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR1900021077 

最近更新日期:

Date of Last Refreshed on:

2019-01-27 14:38:27 

注册时间:

Date of Registration:

2019-01-27 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

胃静脉曲张出血的二级预防

Public title:

Secondary Prophylaxis Of Gastric Variceal Bleed

注册题目简写:

English Acronym:

研究课题的正式科学名称:

内镜下单纯胃底组织胶注射和钛夹辅助的胃底组织胶注射在胃静脉曲张二级预防中的比较

Scientific title:

Gastric Tissue Glue Injection Versus Clip-Assisted Gastric Tissue Glue Injection On Secondary Prophylaxis Of Gastric Varices.

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

孙若楠 

研究负责人:

张春清 

Applicant:

Ruonan Sun 

Study leader:

Chunqing Zhang 

申请注册联系人电话:

Applicant telephone:

+86 15634056179

研究负责人电话:

Study leader's telephone:

+86 13583188661

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

m15634056179@163.com

研究负责人电子邮件:

Study leader's E-mail:

zhangchunqing_sdu@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东济南市历下区经十路9677号

研究负责人通讯地址:

山东济南市历下区经十路9677号

Applicant address:

9677 Jingshi Road, Lixia District, Ji'nan, China

Study leader's address:

9677 Jingshi Road, Lixia District, Ji'nan, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

山东省立医院

Applicant's institution:

Shandong Provincial Hospital

研究负责人所在单位:

山东省立医院

Affiliation of the Leader:

Shandong Provincial Hospital

是否获伦理委员会批准:

否/No

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

山东省立医院

Primary sponsor:

Shandong Provincial Hospital

研究实施负责(组长)单位地址:

济南市历下区经十路9677号

Primary sponsor's address:

9677 Jingshi Road, Lixia District, Ji'nan, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东

市(区县):

济南

Country:

China

Province:

Shandong

City:

Jinan

单位(医院):

山东省立医院

具体地址:

济南市历下区经十路9677号

Institution
hospital:

Shandong Provincial Hospital

Address:

9677 Jingshi Road, Lixia District, Ji'nan, China

国家:

中国

省(直辖市):

北京

市(区县):

北京

Country:

China

Province:

Beijing

City:

Beijing

单位(医院):

北京地坛医院

具体地址:

北京市朝阳区京顺东街8号

Institution
hospital:

Beijing Ditan Hospital

Address:

8 Jingshun Street East, Chaoyang District, Beijing

国家:

中国

省(直辖市):

安徽

市(区县):

合肥

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

安徽医科大学第一附属医院

具体地址:

合肥市绩溪路218号

Institution
hospital:

The first affiliated hospital of anhui medical university

Address:

218 Jixi Road, Hefei, Anhui, China

国家:

中国

省(直辖市):

贵州

市(区县):

遵义

Country:

China

Province:

Guizhou

City:

Zunyi

单位(医院):

遵义医学院附属医院

具体地址:

遵义市汇川区大连路149号

Institution
hospital:

Affiliated hospital of zunyi medical university

Address:

149 Dalian Road, Huichuan District, Zunyi, Guizhou, China

国家:

中国

省(直辖市):

上海

市(区县):

上海

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

上海中山医院

具体地址:

上海市徐汇区枫林路180号

Institution
hospital:

Shanghai zhongshan hospital

Address:

180 Fenglin Road, Xuhui District, Shanghai, China

国家:

中国

省(直辖市):

Jinan

市(区县):

Country:

China

Province:

Shandong Provincial

City:

单位(医院):

山东省立三院

具体地址:

济南市天桥区无影山中路11号

Institution
hospital:

Shandong Provincial Third Hospital

Address:

No.11, Wujingshan Middle Road, Tianqiao District, Jinan, China

经费或物资来源:

泰山学者经费;国家自然科学基金

Source(s) of funding:

Foundation of Taishan Scholar;National Natural Science Foundation of China

Target disease:

Gastric Varices

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

比较内镜下单纯胃底组织胶注射和钛夹辅助的胃底组织胶注射在胃静脉曲张二级预防中效果  

Objectives of Study:

Compare the effect of Gastric Tissue Glue Injection and Clip-Assisted Gastric Tissue Glue Injection On Secondary Prophylaxis Of Gastric Varices.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.诊断为肝硬化.
2.既往有胃静脉曲张(GOV2型或IGV1型)出血史.
3.存在胃肾分流.

Inclusion criteria

1. Cirrhosis;
2. Patients who had bled from GOV2 or IGV1;
3. Presence of gastrorenal shunt.

排除标准:

1.胃底静脉曲张既往有包括内镜治疗,NSBB,TIPS或手术治疗.
2.非肝硬化门脉高压症.
3.内镜下胃底组织胶注射或钛夹辅助组织胶注射禁忌.
4.门静脉海绵样变性.
5.肝肾综合征.
6.证实包括肝细胞癌在内的恶性肿瘤或其它将缩短患者寿命的疾病.
7.肾脏替代治疗下的末期肾病.
8.心肺功能衰竭.
9.孕妇或者受试者拒绝参加试验.

Exclusion criteria:

1. Previous treatment of gastric varices, including endoscopic therapy, NSBB, TIPS, or surgery;
2. Non-cirrhotic portal hypertension;
3. Contraindications to the treatment of tissue glue or endoscopic titanium clip assisted the treatment of tissue glue;
4. Portal cavernoma;
5. Hepatorenal syndrome;
6. Proven malignancy including hepatocellular carcinoma;
7. End-stage renal disease under renal replacement therapy;
8. Cardiorespiratory failure;
9. Pregnancy or patients not giving informed consent for procedures.

研究实施时间:

Study execute time:

From 2019-02-28 00:00:00 To 2022-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-02-28 00:00:00 To 2020-02-28 00:00:00  

干预措施:

Interventions:

组别:

对照组

样本量:

35

Group:

Contral group

Sample size:

干预措施:

胃底组织胶注射

干预措施代码:

Intervention:

Gastric Tissue Glue Injection

Intervention code:

组别:

治疗组

样本量:

35

Group:

Intervention group

Sample size:

干预措施:

钛夹辅助的胃底组织胶注射

干预措施代码:

Intervention:

Clip-Assisted Gastric Tissue Glue Injection

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东 

市(区县):

济南 

Country:

China 

Province:

Shandong 

City:

Jinan 

单位(医院):

山东省立医院 

单位级别:

三甲 

Institution
hospital:

Shandong Provincial Hospital

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

北京 

市(区县):

北京 

Country:

China 

Province:

Beijing 

City:

Beijing 

单位(医院):

北京地坛医院 

单位级别:

三甲 

Institution
hospital:

Beijing Ditan Hospital

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

安徽 

市(区县):

合肥 

Country:

China 

Province:

Anhui 

City:

Hefei 

单位(医院):

安徽医科大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

The first affiliated hospital of anhui medical university

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

贵州 

市(区县):

遵义 

Country:

China 

Province:

Guizhou 

City:

Zunyi 

单位(医院):

遵义医学院附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated hospital of zunyi medical university

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

上海 

市(区县):

上海 

Country:

China 

Province:

Shanghai 

City:

Shanghai 

单位(医院):

上海中山医院 

单位级别:

三甲 

Institution
hospital:

Shanghai zhongshan hospital

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

山东 

市(区县):

济南 

Country:

China 

Province:

Shandong Provincial 

City:

Jinan 

单位(医院):

山东省立三院 

单位级别:

三甲 

Institution
hospital:

Shandong Provincial Third Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东 

市(区县):

Jinan 

Country:

China 

Province:

Shandong Provincial 

City:

Jinan 

单位(医院):

中国人民解放军第九六〇医院 

单位级别:

三甲 

Institution
hospital:

The 960th Hospital of People’s Liberation Army of China (PLA)

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东 

市(区县):

泰安 

Country:

China 

Province:

Shandong Provincial 

City:

Taian 

单位(医院):

泰安市中心医院 

单位级别:

三甲 

Institution
hospital:

Tai'an Central Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东 

市(区县):

青岛 

Country:

China 

Province:

Shandong Provincial 

City:

qingdao 

单位(医院):

青岛大学医学院附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated Hospital of Qingdao University Medical College

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东 

市(区县):

临沂 

Country:

China 

Province:

Shandong Provincial 

City:

linyi 

单位(医院):

临沂市人民医院 

单位级别:

三甲 

Institution
hospital:

Linyi People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东 

市(区县):

聊城 

Country:

China 

Province:

Shandong Provincial 

City:

Liaocheng 

单位(医院):

聊城市人民医院 

单位级别:

三甲 

Institution
hospital:

Liaocheng People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

Shandong 

市(区县):

滨州 

Country:

China 

Province:

Shandong Provincial 

City:

Binzhou 

单位(医院):

滨州医学院附属医院 

单位级别:

三甲 

Institution
hospital:

Binzhou Medical University Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

出血率

指标类型:

主要指标

Outcome:

Bleeding rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生存率

指标类型:

次要指标

Outcome:

Survival rate

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

异位栓塞率

指标类型:

主要指标

Outcome:

Ectopic embolism rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肝性脑病发生率

指标类型:

次要指标

Outcome:

Incidence of hepatic encephalopathy

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

各中心研究人员应用网上中心随机化系统(https://xjopen.magmin.cn),患者 1:1的比例进行随机分组.

Randomization Procedure (please state who generates the random number sequence and by what method):

The researchers of five centers use a central random system(https://xjopen.magmin.cn)to randomize the groups in a 1:1 ratio。

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

未说明

Blinding:

Not stated

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成后6个月内公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Within six months after the trial complete

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

通过病例记录表进行数据采集和管理.

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection will be conducted with CRF.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2019-01-27 14:38:27